Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)

Kanesvaran, R.Biswas, B.Danchaivijitr, P.Lim, C. S.Karabulut, B.Wong, Y. F.Coskun, H. S.2024-06-122024-06-1220190923-75341569-8041https://hdl.handle.net/20.500.14551/26757European-Society-for-Medical-Oncology (ESMO) Asia Congress -- NOV 22-24, 2019 -- Singapore, SINGAPORE[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keywords]Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)Conference Object30Q1WOS:000503487700531